Anupam Rama
Stock Analyst at JP Morgan
(3.38)
# 1,034
Out of 4,667 analysts
244
Total ratings
41.08%
Success rate
5.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences | Maintains: Overweight | $19 → $21 | $9.08 | +131.28% | 4 | Nov 14, 2024 | |
| SLDB Solid Biosciences | Maintains: Overweight | $15 → $12 | $4.96 | +141.94% | 6 | Nov 12, 2024 | |
| ANAB AnaptysBio | Maintains: Overweight | $75 → $66 | $20.31 | +224.96% | 9 | Nov 12, 2024 | |
| FOLD Amicus Therapeutics | Maintains: Overweight | $16 → $17 | $9.59 | +77.27% | 13 | Nov 12, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Underweight | n/a | $1.07 | - | 7 | Nov 11, 2024 | |
| VERA Vera Therapeutics | Maintains: Overweight | $72 → $75 | $45.75 | +63.93% | 8 | Nov 5, 2024 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Overweight | $39 → $40 | $21.21 | +88.59% | 3 | Nov 5, 2024 | |
| ZLAB Zai Lab | Maintains: Overweight | $38 → $44 | $26.23 | +67.75% | 11 | Oct 21, 2024 | |
| NUVL Nuvalent | Maintains: Overweight | $100 → $125 | $91.17 | +37.11% | 6 | Oct 4, 2024 | |
| PROK ProKidney | Initiates: Neutral | n/a | $1.65 | - | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $17 | $11.23 | +51.38% | 7 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $23 | $17.86 | +28.78% | 3 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $64 → $57 | $27.49 | +107.35% | 15 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $64 → $68 | $37.44 | +81.62% | 5 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $31 | $8.28 | +274.40% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $69 → $66 | $25.54 | +158.42% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $46 → $43 | $23.04 | +86.63% | 8 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $181 | $123.29 | +46.81% | 16 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 → $33 | $15.95 | +106.90% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $10 | $4.91 | +103.67% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $38 → $36 | $13.62 | +164.32% | 3 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.99 | - | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $177 → $175 | $110.86 | +57.86% | 11 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $0.87 | - | 3 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $11 → $13 | $5.16 | +151.94% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $18 | $8.74 | +105.95% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $88 → $92 | $46.40 | +98.28% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.57 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $1.35 | +566.67% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $5.79 | - | 6 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.58 | - | 2 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 | $10.68 | +2,240.82% | 7 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.51 | - | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $58 | $49.86 | +16.33% | 1 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $7 → $12 | $9.97 | +20.36% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $29 → $37 | $6.74 | +448.96% | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $55 | $40.65 | +35.30% | 3 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $28 | $2.64 | +960.61% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $54 | $54.62 | -1.14% | 10 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $45 | $1.48 | +2,940.54% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $27 | $29.99 | -9.97% | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $7.85 | +409.55% | 1 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $133 → $137 | $248.79 | -44.93% | 9 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $10.54 | +270.02% | 1 | Dec 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $48 | $6.37 | +653.53% | 5 | Jul 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $12.17 | - | 2 | May 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $18 | $1.05 | +1,614.29% | 2 | Mar 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $2.04 | +1,370.59% | 1 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $41.96 | - | 2 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.52 | - | 2 | Jul 21, 2017 |
Cogent Biosciences
Nov 14, 2024
Maintains: Overweight
Price Target: $19 → $21
Current: $9.08
Upside: +131.28%
Solid Biosciences
Nov 12, 2024
Maintains: Overweight
Price Target: $15 → $12
Current: $4.96
Upside: +141.94%
AnaptysBio
Nov 12, 2024
Maintains: Overweight
Price Target: $75 → $66
Current: $20.31
Upside: +224.96%
Amicus Therapeutics
Nov 12, 2024
Maintains: Overweight
Price Target: $16 → $17
Current: $9.59
Upside: +77.27%
RAPT Therapeutics
Nov 11, 2024
Downgrades: Underweight
Price Target: n/a
Current: $1.07
Upside: -
Vera Therapeutics
Nov 5, 2024
Maintains: Overweight
Price Target: $72 → $75
Current: $45.75
Upside: +63.93%
Kiniksa Pharmaceuticals International,
Nov 5, 2024
Maintains: Overweight
Price Target: $39 → $40
Current: $21.21
Upside: +88.59%
Zai Lab
Oct 21, 2024
Maintains: Overweight
Price Target: $38 → $44
Current: $26.23
Upside: +67.75%
Nuvalent
Oct 4, 2024
Maintains: Overweight
Price Target: $100 → $125
Current: $91.17
Upside: +37.11%
ProKidney
Sep 30, 2024
Initiates: Neutral
Price Target: n/a
Current: $1.65
Upside: -
Sep 24, 2024
Maintains: Overweight
Price Target: $14 → $17
Current: $11.23
Upside: +51.38%
Sep 13, 2024
Maintains: Overweight
Price Target: $20 → $23
Current: $17.86
Upside: +28.78%
Sep 13, 2024
Maintains: Overweight
Price Target: $64 → $57
Current: $27.49
Upside: +107.35%
Sep 4, 2024
Maintains: Overweight
Price Target: $64 → $68
Current: $37.44
Upside: +81.62%
Aug 8, 2024
Maintains: Overweight
Price Target: $33 → $31
Current: $8.28
Upside: +274.40%
Aug 8, 2024
Maintains: Overweight
Price Target: $69 → $66
Current: $25.54
Upside: +158.42%
Aug 7, 2024
Maintains: Overweight
Price Target: $46 → $43
Current: $23.04
Upside: +86.63%
Aug 7, 2024
Maintains: Overweight
Price Target: $173 → $181
Current: $123.29
Upside: +46.81%
Aug 6, 2024
Maintains: Overweight
Price Target: $34 → $33
Current: $15.95
Upside: +106.90%
Aug 6, 2024
Maintains: Neutral
Price Target: $12 → $10
Current: $4.91
Upside: +103.67%
Aug 6, 2024
Maintains: Overweight
Price Target: $38 → $36
Current: $13.62
Upside: +164.32%
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.99
Upside: -
May 3, 2024
Maintains: Overweight
Price Target: $177 → $175
Current: $110.86
Upside: +57.86%
Apr 22, 2024
Upgrades: Neutral
Price Target: n/a
Current: $0.87
Upside: -
Apr 1, 2024
Maintains: Overweight
Price Target: $11 → $13
Current: $5.16
Upside: +151.94%
Mar 27, 2024
Maintains: Overweight
Price Target: $19 → $18
Current: $8.74
Upside: +105.95%
Mar 18, 2024
Maintains: Overweight
Price Target: $88 → $92
Current: $46.40
Upside: +98.28%
Dec 22, 2023
Downgrades: Underweight
Price Target: n/a
Current: $0.57
Upside: -
Aug 16, 2023
Maintains: Neutral
Price Target: $8 → $9
Current: $1.35
Upside: +566.67%
Jul 25, 2023
Downgrades: Underweight
Price Target: n/a
Current: $5.79
Upside: -
Nov 10, 2022
Downgrades: Underweight
Price Target: n/a
Current: $0.58
Upside: -
Jul 13, 2022
Downgrades: Neutral
Price Target: $250
Current: $10.68
Upside: +2,240.82%
Mar 8, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.51
Upside: -
Dec 10, 2021
Initiates: Overweight
Price Target: $58
Current: $49.86
Upside: +16.33%
Nov 5, 2021
Upgrades: Neutral
Price Target: $7 → $12
Current: $9.97
Upside: +20.36%
Oct 25, 2021
Upgrades: Neutral
Price Target: $29 → $37
Current: $6.74
Upside: +448.96%
Oct 12, 2021
Upgrades: Overweight
Price Target: $55
Current: $40.65
Upside: +35.30%
Aug 10, 2021
Initiates: Overweight
Price Target: $28
Current: $2.64
Upside: +960.61%
Mar 1, 2021
Downgrades: Neutral
Price Target: $54
Current: $54.62
Upside: -1.14%
Jan 11, 2021
Initiates: Overweight
Price Target: $45
Current: $1.48
Upside: +2,940.54%
Oct 12, 2020
Initiates: Overweight
Price Target: $27
Current: $29.99
Upside: -9.97%
Aug 18, 2020
Initiates: Overweight
Price Target: $40
Current: $7.85
Upside: +409.55%
May 7, 2020
Downgrades: Neutral
Price Target: $133 → $137
Current: $248.79
Upside: -44.93%
Dec 24, 2019
Initiates: Overweight
Price Target: $39
Current: $10.54
Upside: +270.02%
Jul 12, 2019
Downgrades: Neutral
Price Target: $29 → $48
Current: $6.37
Upside: +653.53%
May 10, 2018
Upgrades: Overweight
Price Target: n/a
Current: $12.17
Upside: -
Mar 6, 2018
Maintains: Overweight
Price Target: $15 → $18
Current: $1.05
Upside: +1,614.29%
Dec 4, 2017
Initiates: Overweight
Price Target: $30
Current: $2.04
Upside: +1,370.59%
Nov 16, 2017
Upgrades: Neutral
Price Target: n/a
Current: $41.96
Upside: -
Jul 21, 2017
Downgrades: Neutral
Price Target: n/a
Current: $3.52
Upside: -